BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED revenue for the last year amounted to 5.18 B CNY, the most of which — 5.16 B CNY — came from its highest performing source at the moment, Blood Products, the year earlier bringing 4.24 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED 5.16 B CNY, and the year before that — 4.13 B CNY.